Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4

M. Masetti, G. Acquaviva, M. Visani, G. Tallini, A. Fornelli, M. Ragazzi, F. Vasuri, D. Grifoni, S. Di Giacomo, S. Fiorino, R. Lombardi, D. Tuminati, M. Ravaioli, C. Fabbri, M.L. Bacchi-Reggiani, A. Pession, E. Jovine, D. de Biase

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)323-334
Number of pages12
JournalCancer Biomarkers
Volume21
Issue number2
DOIs
Publication statusPublished - Jan 2 2018

Cite this

Masetti, M., Acquaviva, G., Visani, M., Tallini, G., Fornelli, A., Ragazzi, M., ... de Biase, D. (2018). Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. Cancer Biomarkers, 21(2), 323-334. https://doi.org/10.3233/CBM-170464

Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. / Masetti, M.; Acquaviva, G.; Visani, M.; Tallini, G.; Fornelli, A.; Ragazzi, M.; Vasuri, F.; Grifoni, D.; Di Giacomo, S.; Fiorino, S.; Lombardi, R.; Tuminati, D.; Ravaioli, M.; Fabbri, C.; Bacchi-Reggiani, M.L.; Pession, A.; Jovine, E.; de Biase, D.

In: Cancer Biomarkers, Vol. 21, No. 2, 02.01.2018, p. 323-334.

Research output: Contribution to journalArticle

Masetti, M, Acquaviva, G, Visani, M, Tallini, G, Fornelli, A, Ragazzi, M, Vasuri, F, Grifoni, D, Di Giacomo, S, Fiorino, S, Lombardi, R, Tuminati, D, Ravaioli, M, Fabbri, C, Bacchi-Reggiani, ML, Pession, A, Jovine, E & de Biase, D 2018, 'Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4', Cancer Biomarkers, vol. 21, no. 2, pp. 323-334. https://doi.org/10.3233/CBM-170464
Masetti, M. ; Acquaviva, G. ; Visani, M. ; Tallini, G. ; Fornelli, A. ; Ragazzi, M. ; Vasuri, F. ; Grifoni, D. ; Di Giacomo, S. ; Fiorino, S. ; Lombardi, R. ; Tuminati, D. ; Ravaioli, M. ; Fabbri, C. ; Bacchi-Reggiani, M.L. ; Pession, A. ; Jovine, E. ; de Biase, D. / Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4. In: Cancer Biomarkers. 2018 ; Vol. 21, No. 2. pp. 323-334.
@article{42ba550d24a1403eaf6dac0947a3b57d,
title = "Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4",
author = "M. Masetti and G. Acquaviva and M. Visani and G. Tallini and A. Fornelli and M. Ragazzi and F. Vasuri and D. Grifoni and {Di Giacomo}, S. and S. Fiorino and R. Lombardi and D. Tuminati and M. Ravaioli and C. Fabbri and M.L. Bacchi-Reggiani and A. Pession and E. Jovine and {de Biase}, D.",
note = "Cited By :2 Export Date: 30 August 2018",
year = "2018",
month = "1",
day = "2",
doi = "10.3233/CBM-170464",
language = "English",
volume = "21",
pages = "323--334",
journal = "Cancer Biomarkers",
issn = "1574-0153",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4

AU - Masetti, M.

AU - Acquaviva, G.

AU - Visani, M.

AU - Tallini, G.

AU - Fornelli, A.

AU - Ragazzi, M.

AU - Vasuri, F.

AU - Grifoni, D.

AU - Di Giacomo, S.

AU - Fiorino, S.

AU - Lombardi, R.

AU - Tuminati, D.

AU - Ravaioli, M.

AU - Fabbri, C.

AU - Bacchi-Reggiani, M.L.

AU - Pession, A.

AU - Jovine, E.

AU - de Biase, D.

N1 - Cited By :2 Export Date: 30 August 2018

PY - 2018/1/2

Y1 - 2018/1/2

U2 - 10.3233/CBM-170464

DO - 10.3233/CBM-170464

M3 - Article

VL - 21

SP - 323

EP - 334

JO - Cancer Biomarkers

JF - Cancer Biomarkers

SN - 1574-0153

IS - 2

ER -